Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in India. Eli Lilly has launched Lormalzi, a new monthly treatment for early Alzheimer's disease. This drug targets amyloi… For the full story, visit the source.
HealthMaharashtra
Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vial
Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in India. Eli Lilly has launched Lormalzi, a new monthly treatment for early Alzheimer's disease. This drug targets amyloi…
By Rica Bhattacharyya· The Times of India· 5 months ago· 2 min read
This summary is sourced from The Times of India. Read the full article at:The Times of India